Zobrazeno 121 - 130
of 209
pro vyhledávání: '"Andrew Haydon"'
Autor:
Richard F. Kefford, Annie Wong, John J. Park, Oliver Klein, Alexander M. Menzies, Jonathan Cebon, Grant A. McArthur, Georgina V. Long, Alexander Guminski, Andrew Haydon, Serigne Lo, Sagun Parakh, Martin Drummond, Wen Xu, Catherine Rowe, Matteo S. Carlino, Rajat Rai, Shehara Mendis, Miles C. Andrews
Publikováno v:
British Journal of Cancer
Background: There is limited data on the efficacy of anti-programmed death 1 (PD-1) antibodies in patients (pts) with melanoma brain metastasis (BM), particularly those which are symptomatic. Method: We retrospectively assessed pts with melanoma BM t
Autor:
Maggie Moore, Elizabeth Blackley, Catriona McLean, Peter Bergin, Andrew Haydon, Rebecca Y. Tay, Sanjeev Gill
Publikováno v:
British journal of cancer. 117(7)
Immune-mediated myocarditis is an uncommon adverse effect of immune checkpoint inhibition and is associated with a high rate of mortality. In this reported case, a 64-year-old woman with right temporo-parietal glioblastoma IDH-WT was treated with niv
Autor:
Victoria, Atkinson, Georgina V, Long, Alexander M, Menzies, Grant, McArthur, Matteo S, Carlino, Michael, Millward, Rachel, Roberts-Thomson, Benjamin, Brady, Richard, Kefford, Andrew, Haydon, Jonathan, Cebon
Publikováno v:
Asia-Pacific journal of clinical oncology. 12
BRAF mutations occur commonly in metastatic melanomas and inhibition of mutant BRAF and the downstream kinase MEK results in rapid tumor regression and prolonged survival in patients. Combined therapy with BRAF and MEK inhibition improves response ra
Autor:
P. Ranchod, Andrew Haydon, Karen Oliva, S. Skinner, W. Roger, C. Peter, Matthew Grant, F. Chip, A. Polglase, Y. Antill, J. Shapiro, Eva Segelov, Melvin Chin, Paul J. McMurrick, Lewis Au, Simon Wilkins
Publikováno v:
Annals of Oncology. 27
Autor:
Robin E. Smith, Di Yu, Andrew Haydon, Rachel Ward, Menno Van Zelm, Simone Reinwald, Gishan Ratnayake, Sashendra Senthi
Publikováno v:
Journal of Clinical Oncology. 37:e14039-e14039
e14039 Background: Combining stereotactic ablative radiotherapy (SABR) and anti-PD1 therapy may result in synergism but the response and toxicity rates has not been established. Biomarkers to predict clinical outcomes in this setting could improve pa
Autor:
Mark Shackleton, Maggie Moore, Di Yu, Robin E. Smith, Gishan Ratnayake, Jeremy D Ruben, Menno Van Zelm, Rachel Ward, Mark Voskoboynik, Andrew Haydon, Simone Reinwald, Sashendra Senthi
Publikováno v:
Journal of Clinical Oncology. 37:9557-9557
9557 Background: There is growing evidence to suggest synergism between stereotactic ablative radiotherapy (SABR) and immunotherapy (IO) against metastatic melanoma. The optimal timing and dosing of SABR for this purpose has not been established. Her
Autor:
Jeanne Tie, Christos S. Karapetis, Cristian Tomasetti, Peter Gibbs, Belinda Lee, Suzanne Kosmider, Joshua D. Cohen, Timothy J. Price, Niall C. Tebbutt, Rachel Wong, Nickolas Papadopoulos, Lu Li, Andrew Haydon, Desmond Yip, Kenneth W. Kinzler, Matthew Burge, Yuxuan Wang, Bert Vogelstein, Margaret Lee, Hui-Li Wong
Publikováno v:
Journal of Clinical Oncology. 37:3518-3518
3518 Background: Studies in multiple tumor types have demonstrated the prognostic impact of ctDNA analysis after curative intent surgery. Emerging data suggest that conversion of ctDNA from detectable to undetectable after adjuvant chemotherapy may r
Autor:
Mario Mandalà, Andrew Haydon, Stéphane Dalle, Matteo S. Carlino, Paolo A. Ascierto, Christian U. Blank, Victoria Atkinson, Muhammad A. Khattak, Michal Kicinski, Susana Puig, Mikhail Lichinitser, Alexander C.J. van Akkooi, Shahneen Sandhu, Alexander M.M. Eggermont, Stefan Suciu, Nageatte Ibrahim, Georgina V. Long, Clemens Krepler, Caroline Robert, Sandrine Marreaud
Publikováno v:
Journal of Clinical Oncology. 37:2517-2517
2517 Background: Several studies suggested that patients (pts) with an immune-related adverse event (irAE) during immunotherapy have better outcomes than those without. It remains uncertain whether these observations can be explained by guarantee-tim
Autor:
Galina Polekhina, Wendy B. Bernstein, Christopher A. Reid, Finlay A. Macrae, Asad Umar, Anne M. Murray, Raj C. Shah, Jessica E. Lockery, Brenda Kirpach, Andrew T. Chan, Josie van London, Leslie G. Ford, John Zalcberg, Andrew Haydon, Joanne Ryan, Rory Wolfe, John J McNeil, Mark Nelson, Jeanne Tie, Robyn L. Woods, Ellen Richmond, Peter Gibbs, Yin Cao, Suzanne G Orchard
Publikováno v:
Gastroenterology. 156:S-78
Autor:
Rhiannon J. Walters, Belinda N. Nagler, Aung Ko Win, Mark Clendenning, Sally-Ann Pearson, Christophe Rosty, Daniel D. Buchanan, Dallas R. English, Joanne P. Young, Michael A. McGuckin, David Packenas, Graham G. Giles, Elizabeth A. Williamson, John L. Hopper, Michael Walsh, Andrew Haydon, Mark A. Jenkins
Publikováno v:
Modern Pathology. 26:1642-1656
Mucinous differentiation is associated with both CpG island methylator phenotype and microsatellite instability in colorectal cancer. The mucinous phenotype derives from abundant expression of the colonic goblet cell mucin, MUC2, and de novo expressi